Hedegaard H, Johnson RL. An updated international classification of diseases, 10th revision, clinical modification (ICD-10-CM) surveillance case definition for injury hospitalizations. Nat Health Statis Rep. 2019;136:1–8.

Google Scholar 

Cj N, Christina C, Alexandra RB, Jimmie H, AndrewJ R. Are gold standard depression measures appropriate for use in geriatric cancer patients? a systematic evaluation of self-report depression instruments used with geriatric, cancer, and geriatric cancer samples. J Clin Oncol. 2010;28:348–56.

Article  Google Scholar 

Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119–38.

Article  PubMed  PubMed Central  Google Scholar 

James SLAD. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392:1789–858.

Article  Google Scholar 

Incze MA. I’m worried about depression-what should i know? JAMA Intern Med. 2019. https://doi.org/10.1001/jamainternmed.2019.0637.

Article  PubMed  Google Scholar 

Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet. 2007;370:841–50.

Article  PubMed  PubMed Central  Google Scholar 

Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6:211–24.

Article  PubMed  Google Scholar 

Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006;7:137–51.

Article  CAS  PubMed  Google Scholar 

Qaseem A, Owens DK, Etxeandia-Ikobaltzeta I, Tufte J, Cross JT, Wilt TJ. Nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder: a living clinical guideline from the american college of physicians. Ann Intern Med. 2023. https://doi.org/10.7326/M22-2056.

Article  PubMed  PubMed Central  Google Scholar 

Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord. 2000;58:19–36.

Article  CAS  PubMed  Google Scholar 

Hatcher S, Arroll B. Newer antidepressants for the treatment of depression in adults. BMJ. 2012;344: d8300.

Article  PubMed  Google Scholar 

Jelen LA, Stone JM. Ketamine for depression. Int Rev Psychiatry. 2021;33:207–28.

Article  PubMed  Google Scholar 

Rosenblat JD, McIntyre RS, Alves GS, Fountoulakis KN, Carvalho AF. Beyond monoamines-novel targets for treatment-resistant depression: a comprehensive review. Curr Neuropharmacol. 2015;13:636–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA. The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom. 2016;85:270–88.

Article  PubMed  Google Scholar 

Khin NA, Chen YF, Yang Y, Yang P, Laughren TP. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US food and drug administration in support of new drug applications. J Clin Psychiatry. 2011;72:464–72.

Article  PubMed  Google Scholar 

Kim J, Farchione T, Potter A, Chen Q, Temple R. esketamine for treatment-resistant depression—first FDA-approved antidepressant in a new class. New Engl J Med. 2019. https://doi.org/10.1056/NEJMp1903305.

Article  PubMed  Google Scholar 

McClintock SM, Reti IM, Carpenter LL, McDonald WM, Dubin M, Taylor SF, et al. Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J Clin Psychiatry. 2018. https://doi.org/10.4088/JCP.16cs10905.

Article  PubMed  PubMed Central  Google Scholar 

Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107:234–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hammen C. Stress and depression. Annu Rev Clin Psychol. 2005;1:293–319.

Article  PubMed  Google Scholar 

Kraus C, Castren E, Kasper S, Lanzenberger R. Serotonin and neuroplasticity—links between molecular, functional and structural pathophysiology in depression. Neurosci Biobehav Rev. 2017;77:317–26.

Article  CAS  PubMed  Google Scholar 

Liu L, Wang H, Chen X, Zhang Y, Zhang H, Xie P. Gut microbiota and its metabolites in depression: from pathogenesis to treatment. EBioMedicine. 2023;90: 104527.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nutt DJ. Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry. 2008;69:4–7.

PubMed  Google Scholar 

Price RB, Duman R. Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. Mol Psychiatry. 2020;25:530–43.

Article  PubMed  Google Scholar 

Mbad F, Rhab E, Mdua D, Gbra G, Ajda D, Jjma D, et al. Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression. Biol Psychiat. 2012;72:562–71.

Article  Google Scholar 

Li Y, Zhu X, Ju S, Yan J, Wang D, Zhu Y, et al. Detection of volume alterations in hippocampal subfields of rats under chronic unpredictable mild stress using 7T MRI: a follow-up study. J Magnet Reson Imag. 2017. https://doi.org/10.1002/jmri.25667.

Article  Google Scholar 

Majd F, Davd D, Cfford J. Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol. 2012;8:189–202.

Article  Google Scholar 

Tunc-Ozcan E, Peng CY, Zhu Y, Dunlop SR, Contractor A, Kessler JA. Activating newborn neurons suppresses depression and anxiety-like behaviors. Nat Commun. 2019. https://doi.org/10.1038/s41467-019-11641-8.

Article  PubMed  PubMed Central  Google Scholar 

Hultman R, Mague SD, Li Q, Katz BM, Michel N, Lin L, et al. Dysregulation of prefrontal cortex-mediated slow-evolving limbic dynamics drives stress-induced emotional pathology. Neuron. 2016;91:439–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wood M, Adil O, Wallace T, Fourman S, Wilson SP, Herman JP, et al. Infralimbic prefrontal cortex structural and functional connectivity with the limbic forebrain: a combined viral genetic and optogenetic analysis. Brain Struct Funct. 2019;224:73–97.

Article  PubMed  Google Scholar 

Jensen M, Overgaard M. Neural plasticity and consciousness. Front Psychol. 2011;2:191.

Article  PubMed  PubMed Central  Google Scholar 

Zhou XT, Bao WD, Liu D, Zhu LQ. Targeting the neuronal activity of prefrontal cortex: new directions for the therapy of depression. Cur Neurophar. 2019. https://doi.org/10.2174/1570159X17666191101124017.

Article  Google Scholar 

David J, Gormley S, McIntosh AL, Kebede V, Thuery G, Varidaki A, Coffey ET, Harkin A. L-alpha-amino adipic acid provokes depression-like behaviour and a stress related increase in dendritic spine density in the pre-limbic cortex and hippocampus in rodents. Behav Brain Res. 2019. https://doi.org/10.1016/j.bbr.2019.01.015.

Article  PubMed  Google Scholar 

Xiaoling G, Wenqi Q, Yueyun L, Yifang Z, Hongbo Z, Jiaxu C. Effects of refined xiaoyaosan on depressive-like behaviors in rats with chronic unpredictable mild stress through neurosteroids their synthesis and metabolic enzymes. Molecules. 2017. https://doi.org/10.3390/molecules22081386.

Article  Google Scholar 

Grogans SE, Fox AS, Shackman AJ. The amygdala and depression: a sober reconsideration. Am J Psychiatry. 2022;179:454–7.

Article